Market
Vivos to buy 50% stake in SOD Sciences’ pseudohypoxia test
Vivos Therapeutics has agreed to acquire an 11% fully diluted equity stake in SOD Sciences and a 50% co-ownership interest in SOD Sciences' pseudohypoxia early-warning diagnostic test. The investment represents a partnership to develop and commercialize the diagnostic technology.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network